Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Jovan-Embiricos Morana Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Granted 35,000 shares @ $0
08/04/2022 4 F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Sold 4,792 shares @ $14.0973, valued at $67.6k
Sold 19,129 shares @ $14.2367, valued at $272.3k
Sold 25,989 shares @ $14.3056, valued at $371.8k
08/01/2022 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Granted 684,622 shares @ $4.61, valued at $3.2M
Granted 325,379 shares @ $4.61, valued at $1.5M
Granted 1,626,898 shares @ $4.61, valued at $7.5M
Granted 1,393,874 shares @ $4.61, valued at $6.4M
Granted 867,678 shares @ $4.61, valued at $4M
Granted 3,253,796 shares @ $4.61, valued at $15M
06/28/2022 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Paid exercise price by delivering 45,078 shares @ $13.39, valued at $603.6k
Exercised 104,845 options to buy @ $4.3, valued at $450.8k
Exercised 35,529 options to buy @ $4.3, valued at $152.8k
06/23/2022 4 F2 Bioscience I 2017 Ltd (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Sold 22,319 shares @ $12.7662, valued at $284.9k
Sold 49,953 shares @ $12.7035, valued at $634.6k
Sold 29,631 shares @ $13.0036, valued at $385.3k
05/19/2022 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Granted 27,500 options to buy @ $4.6, valued at $126.5k
05/16/2022 4 F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Sold 264,072 shares @ $9.2497, valued at $2.4M
Sold 85,319 shares @ $9.9631, valued at $850k
Sold 34,189 shares @ $10.481, valued at $358.3k
Sold 35,158 shares @ $11.2301, valued at $394.8k
03/25/2022 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Granted 7,800 options to buy @ $28.8, valued at $224.6k
01/13/2022 4 F2 Vision SCS (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Disposed of 1,187,734 shares @ $0
11/15/2021 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns: Sold 680 shares @ $24.765, valued at $16.8k
Sold 120 shares @ $24.765, valued at $3k
11/09/2021 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns: Sold 7,124 shares @ $24.8047, valued at $176.7k
Sold 1,257 shares @ $24.8047, valued at $31.2k
Sold 3,243 shares @ $24.7882, valued at $80.4k
Sold 572 shares @ $24.7882, valued at $14.2k
10/29/2021 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns: Sold 1,870 shares @ $24.7775, valued at $46.3k
Sold 330 shares @ $24.7775, valued at $8.2k
10/25/2021 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Allovir, Inc.
Txns: Sold 85 shares @ $24.75, valued at $2.1k
Sold 15 shares @ $24.75, valued at $371.3
Sold 4,864 shares @ $24.7697, valued at $120.5k
Sold 859 shares @ $24.7697, valued at $21.3k
Sold 6,604 shares @ $24.8183, valued at $163.9k
Sold 1,165 shares @ $24.8183, valued at $28.9k
05/27/2021 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Granted 22,500 options to buy @ $21.51, valued at $484k
01/14/2021 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Cullinan Management, Inc.
Txns: Converted 1,136,525 shares @ $0
Converted 2,912,345 shares @ $0
Converted 639,295 shares @ $0
Converted 455,338 shares @ $0
Converted 182,135 shares @ $0
Converted 71,599 shares @ $0
Converted 143,198 shares @ $0
Converted 71,599 shares @ $0
Converted 214,798 shares @ $0
Bought 95,238 shares @ $21, valued at $2M
Bought 104,762 shares @ $21, valued at $2.2M
08/06/2020 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Converted 13,420,970 shares @ $0
Converted 247,011 shares @ $0
Converted 1,399,732 shares @ $0
Converted 411,685 shares @ $0
Bought 100,000 shares @ $17, valued at $1.7M
Bought 2,800,000 shares @ $17, valued at $47.6M
Converted 20,000,000 convertible preferred @ $0
Converted 368,098 convertible preferred @ $0
Converted 2,085,889 convertible preferred @ $0
Converted 613,496 convertible preferred @ $0
07/31/2020 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Allovir, Inc.
Txns: Granted 22,500 options to buy @ $17, valued at $382.5k
12/20/2019 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 458 shares @ $17.006, valued at $7.8k
Sold 2,433 shares @ $17.006, valued at $41.4k
Sold 6,642 shares @ $16.4714, valued at $109.4k
Sold 35,323 shares @ $16.4714, valued at $581.8k
Disposed of 586,153 shares @ $0
Disposed of 13,847 shares @ $0
12/11/2019 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 20,886 shares @ $17.6511, valued at $368.7k
Sold 24,966 shares @ $17.6511, valued at $440.7k
Sold 19,070 shares @ $17.6511, valued at $336.6k
Sold 75,067 shares @ $17.6511, valued at $1.3M
Sold 8,479 shares @ $17.6232, valued at $149.4k
Sold 10,135 shares @ $17.6232, valued at $178.6k
Sold 7,741 shares @ $17.6232, valued at $136.4k
Sold 30,475 shares @ $17.6232, valued at $537.1k
Sold 1,155 shares @ $17.6525, valued at $20.4k
Sold 1,381 shares @ $17.6525, valued at $24.4k
Sold 1,054 shares @ $17.6525, valued at $18.6k
10/24/2019 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 580 shares @ $15.1571, valued at $8.8k
Sold 693 shares @ $15.1571, valued at $10.5k
Sold 530 shares @ $15.1571, valued at $8k
Sold 2,085 shares @ $15.1571, valued at $31.6k
09/24/2019 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 54,907 shares @ $17.9354, valued at $984.8k
Sold 24,446 shares @ $17.9354, valued at $438.4k
Sold 12,537 shares @ $17.9354, valued at $224.9k
Sold 65,633 shares @ $17.9354, valued at $1.2M
Sold 50,134 shares @ $17.9354, valued at $899.2k
Sold 197,343 shares @ $17.9354, valued at $3.5M
Sold 1,535 shares @ $17.3114, valued at $26.6k
Sold 683 shares @ $17.3114, valued at $11.8k
Sold 351 shares @ $17.3114, valued at $6.1k
Sold 1,835 shares @ $17.3114, valued at $31.8k
Sold 1,401 shares @ $17.3114, valued at $24.3k
09/05/2019 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 500 shares @ $17, valued at $8.5k
Sold 100 shares @ $17.03, valued at $1.7k
Sold 3 shares @ $17, valued at $51
Sold 29,128 shares @ $17.0104, valued at $495.5k
Sold 1,200 shares @ $17.0113, valued at $20.4k
Sold 6,700 shares @ $17.0061, valued at $113.9k
Sold 3,700 shares @ $17.0068, valued at $62.9k
Sold 10,559 shares @ $17.0142, valued at $179.7k
Sold 12,214 shares @ $17.5548, valued at $214.4k
02/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2015 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns: Disposed of 251,680 shares @ $0
Disposed of 335,820 shares @ $0
01/12/2015 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns: Disposed of 389,331 shares @ $0
Disposed of 89,261 warrants @ $2.694, valued at $240.5k
12/19/2014 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns: Granted 30,000 options to buy @ $30.97, valued at $929.1k
06/13/2014 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns: Converted 1,794,983 shares @ $0
Converted 871,851 shares @ $0
Bought 587,500 shares @ $8, valued at $4.7M
Converted 227,938 convertible preferred @ $0
Converted 110,713 convertible preferred @ $0
06/10/2014 4 Jovan-Embiricos Morana (10% Owner) has filed a Form 4 on Radius Health, Inc.
Txns: Converted 1,557,328 shares @ $0
Converted 325,627 convertible preferred @ $0
02/19/2014 4 Jovan-Embiricos Morana (Director) has filed a Form 4 on Radius Health, Inc.
Txns: Granted 227,938 convertible preferred @ $61.42, valued at $14M
Granted 110,713 convertible preferred @ $61.42, valued at $6.8M
Granted 569,845 warrants @ $6.142, valued at $3.5M
Granted 276,783 warrants @ $6.142, valued at $1.7M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy